Educational Intervention for Reducing Work Disability in Breast Cancer Survivors

University of Wisconsin (UW)

Status

Completed

Conditions

Breast Cancer

Cancer Survivor

Treatments

Procedure: quality-of-life assessment

Other: questionnaire administration

Other: internet-based intervention

Other: educational intervention

Procedure: management of therapy complications

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT01799031

NCI-2012-03055 (Registry Identifier)

SMPH\ORTHOPEDIC&REHAB\PT (Other Identifier)

A536130 (Other Identifier)

2012-0729 (Other Identifier)

OS12115

Details and patient eligibility

About

This randomized clinical trial studies an educational intervention for reducing work disability in breast cancer survivors. Web sites providing symptom management education may be an effective method to help breast cancer survivors reduce work disability after treatment

Full description

PRIMARY OBJECTIVES:

I. Determine the feasibility and usability of the Work Ability Improvement Through Symptom Management and Ergonomic Strategies (WISE) and empirically evaluate its effect on short-term work ability among breast cancer survivors (BCS).

SECONDARY OBJECTIVES:

I. Explore individual and workplace factors associated with work ability in BCS.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients receive access to the WISE web-based educational intervention to help BCS manage their symptoms, identify ergonomic workplace problems and risks, and implement ergonomic modifications. Patients also receive standard of care comprising symptom management therapies and a pamphlet on employment rights.

ARM II: Patients receive standard of care comprising symptom management therapies and a pamphlet on employment rights.

After completion of study treatment, patients are followed up at 3 and 6 months.

Enrollment

44 patients

Sex

Female

Ages

25 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosed with breast cancer
Employed at time of cancer diagnosis (defined as paid employment > 20 hours/week)
Within six months of completion of active treatment
Working during treatment or intending to return to work following active treatment
Computer and internet access

Exclusion criteria

Patients who do not intend to continue/resume working following treatment
Develop distant metastases or progressive disease
Prior diagnosis of malignancy at any other site except for in situ carcinomas of the cervix or non-melanomatous skin cancers

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

44 participants in 2 patient groups

Arm I (WISE)

Experimental group

Description:

Patients receive access to the WISE web-based educational intervention to help BCS manage their symptoms, identify ergonomic workplace problems and risks, and implement ergonomic modifications. Patients also receive standard of care comprising symptom management therapies and a pamphlet on employment rights.

Treatment:

Other: educational intervention

Procedure: management of therapy complications

Other: questionnaire administration

Other: internet-based intervention

Procedure: quality-of-life assessment

Arm II (control)

Active Comparator group

Description:

Patients receive standard of care comprising symptom management therapies and a pamphlet on employment rights.

Treatment:

Procedure: management of therapy complications